DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
about
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
DNMT3B in vitro knocking-down ...... n of myogenic differentiation.
@en
DNMT3B in vitro knocking-down ...... n of myogenic differentiation.
@nl
type
label
DNMT3B in vitro knocking-down ...... n of myogenic differentiation.
@en
DNMT3B in vitro knocking-down ...... n of myogenic differentiation.
@nl
prefLabel
DNMT3B in vitro knocking-down ...... n of myogenic differentiation.
@en
DNMT3B in vitro knocking-down ...... n of myogenic differentiation.
@nl
P2093
P2860
P356
P1433
P1476
DNMT3B in vitro knocking-down ...... on of myogenic differentiation
@en
P2093
Anna Clerico
Barry Pizer
Carlo Dominici
Cinzia Marchese
Francesca Megiorni
Francesco Marampon
Heather P McDowell
Olga Mannarino
Rajeev Shukla
Simona Camero
P2860
P304
79342-79356
P356
10.18632/ONCOTARGET.12688
P407
P577
2016-11-01T00:00:00Z